Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: Influences of age and sex

Clinical Chemistry

Volumn 52, Issue 1, 2006, Pages 104-111

  Hoogendoorn, Elizabeth H ^a   Hermus, Ad R ^a   De Vegt, Femmie ^a   Ross, H Alec ^a   Verbeek, Andre L M ^a   Kiemeney, Lambertus A L M ^a   Swinkels, Dorine W ^a   Sweep, Fred C G J ^a   Den Heijer, Martin ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; AGE; AGED; ANAMNESIS; ARTICLE; FEMALE; FREE THYROXINE INDEX; HUMAN; HUMAN EXPERIMENT; LIFESTYLE; MALE; NETHERLANDS; NORMAL HUMAN; SEX DIFFERENCE; THYROID FUNCTION; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; FEMALE; HUMANS; HYPOTHYROIDISM; IODIDE PEROXIDASE; IODINE; MALE; MIDDLE AGED; NETHERLANDS; QUESTIONNAIRES; REFERENCE VALUES; SEX FACTORS; THYROID DISEASES; THYROID FUNCTION TESTS; THYROID GLAND; THYROTOXICOSIS; THYROTROPIN; THYROXINE;

EID: 29744459873     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.055194     Document Type: Article

References (32)

1. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160: 526-34.
2. 4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87:489-99.
3. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: the Whickham Survey. Clin Endocrinol (Oxf) 1977;7:481-93.
4. Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P. The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med 1985;145:1386-8.
5. Laurberg P, Pedersen KM, Hreidarsson A, Sigfusson N, Iversen E, Knudsen PR. Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. J Clin Endocrinol Metab 1998;83:765-9.
6. Bagchi N, Brown TR, Parish RF. Thyroid dysfunction in adults over age 55 years. A study in an urban US community. Arch Intern Med 1990;150:785-7.
7. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003;13:3-126.
8. Brussaard JH, Brants HA, Hulshof KF, Kistemaker C, Lowik MR. Iodine intake and urinary excretion among adults in the Netherlands. Eur J Clin Nutr 1997;51(Suppl 3):S59-62.
9. Brussaard JH, Hulshof KF, Kistemaker C, Lowik MR. Adequacy of the iodine supply in The Netherlands. Eur J Clin Nutr 1997; 51(Suppl 4):S11-5.
10. Hollowell JG, Staehling NW, Hannon WH, Flanders DW, Gunter EW, Maberly GF, et al. Iodine nutrition in the United States. Trends and public health implications: iodine excretion data from National Health and Nutrition Examination Surveys I and III (1971-1974 and 1988-1994). J Clin Endocrinol Metab 1998;83:3401-8.
11. Knudsen N, Jorgensen T, Rasmussen S, Christiansen E, Perrild H. The prevalence of thyroid dysfunction in a population with borderline iodine deficiency. Clin Endocrinol (Oxf) 1999;51:361-7.
12. Volzke H, Alte D, Kohlmann T, Ludemann J, Nauck M, John U, et al. Reference intervals of serum thyroid function tests in a previously iodine-deficient area: Thyroid 2005;15:279-85.
13. Wiersinga WM, Podoba J, Srbecky M, van Vessem M, van Beeren HC, Platvoet-Ter Schiphorst MC. A survey of iodine intake and thyroid volume in Dutch schoolchildren: reference values in an iodine-sufficient area an. Eur J Endocrinol 2001;144:595-603.
14. Rees-Wortelboer MM, Schroder-van der Elst JP, Lycklama A, van der Heide D. [Iodine and goiter in The Netherlands]. Ned Tijdschr Geneeskd 1987;131:1821-4.
15. Dremier S, Coppee F, Delange F, Vassart G, Dumont JE, van Sande J. Clinical review 84: Thyroid autonomy: mechanism and clinical effects. J Clin Endocrinol Metab 1996;81:4187-93.
16. Krohn K, Paschke R. Clinical review 133: Progress in understanding the etiology of thyroid autonomy. J Clin Endocrinol Metab 2001;86:3336-45.
17. Volzke H, Ludemann J, Robinson DM, Spieker KW, Schwahn C, Kramer A, et al. The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area. Thyroid 2003;13:803-10:
18. Studer H, Derwahl M. Mechanisms of nonneoplastic endocrine hyperplasia-a changing concept: a review focused on the thyroid gland. Endocr Rev 1995;16:411-26.
19. Demers LM, Spencer CA. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Clin Endocrinol (Oxf) 2003;58:138-40.
20. Mariotti S, Chiovato L, Franceschi C, Pinchera A. Thyroid autoimmunity and aging. Exp Gerontol 1998;33:535-41.
21. Bjoro T, Holmen J, Kruger O, Midthjell K, Hunstad K, Schreiner T, et al. Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). Eur J Endocrinol 2000;143:639-47.
22. Helfand M. Screening for subclinical thyroid dysfunction in non-pregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2004;140:128-41.
23. Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, McDermott MT. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J Clin Endocrinol Metab 2005;90:581-5.
24. Ringel MD, Mazzaferri EL. Subclinical thyroid dysfunction-can there be a consensus about the consensus? J Clin Endocrinol Metab 2005;90:588-90.
25. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004;291:228-38.
26. Surks MI. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J Clin Endocrinol Metab 2005;90:586-7.
27. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty-year foilow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995;43:55-68.
28. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994;331:1249-52.
29. Faber J, Galloe AM. Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. Eur J Endocrinol 1994;130:350-6.
30. Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY. Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab 1996;81:4278-89.
31. Andersen S, Pedersen KM, Bruun NH, Laurberg P. Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 2002;87:1068-72.
32. Browning MC, Ford RP, Callaghan SJ, Fraser CG. Intra- and interindividual biological variation of five analytes used in assessing thyroid function: implications for necessary standards of performance and the interpretation of results. Clin Chem 1986; 32:962-6.